Journal article
Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer
Abstract
PURPOSE: HDRILBT is one of the best methods of palliation for advanced esophageal cancer (AEC) by improving dysphagia-free survival (DFS) and overall survival (OS). This study examines if the addition of EBRT would further improve the outcome by improving DFS in AEC.
METHODS AND MATERIALS: Patients with inoperable AEC were entered into a randomized prospective study. HDRILBT of 16 Gy/2 fractions/3 days was given initially to all patients. …
Authors
Sur R; Donde B; Falkson C; Ahmed N; Levin V; Nag S; Wong R; Jones G
Journal
Brachytherapy, Vol. 3, No. 4, pp. 191–195
Publisher
Elsevier
Publication Date
2004
DOI
10.1016/j.brachy.2004.09.004
ISSN
1538-4721
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedBrachytherapyCarcinoma, Squamous CellDeglutition DisordersDisease-Free SurvivalDose Fractionation, RadiationEsophageal NeoplasmsFemaleFollow-Up StudiesHumansMaleMiddle AgedMultivariate AnalysisNeoplasm StagingPalliative CarePilot ProjectsProspective StudiesRadiotherapy, High-EnergySouth AfricaSurvival RateTomography, X-Ray Computed